期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Commentary on “Outcomes and management of Peyronie’s disease with combined treatment of collagenase clostridium histolyticum, vacuum erection device, and tadalafil”
1
作者 Biagio Barone Luigi Napolitano +1 位作者 Dario Del Biondo Felice Crocetto 《Asian Journal of Andrology》 2025年第6期764-764,共1页
Peyronie's disease(PD)is a challenging condition that significantly impacts male sexual health,often leading to penile curvature,pain,and erectile dysfunction.Treatment options range from conservative pharmacologi... Peyronie's disease(PD)is a challenging condition that significantly impacts male sexual health,often leading to penile curvature,pain,and erectile dysfunction.Treatment options range from conservative pharmacologic approaches to more invasive surgical interventions,with collagenase clostridium histolyticum(CCH)being the only U.S.Food and Drug Administration(FDA)-approved intralesional therapy.However,optimizing treatment strategies to enhance efficacy while minimizing patient burden remains an area of ongoing investigation.^(1,2) 展开更多
关键词 peyronies disease pd conservative pharmacologic approaches collagenase clostridium histolyticum cch being erectile dysfunctiontreatment surgical interventionswith collagenase clostridium histolyticum vacuum erection device Peyronies disease
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部